Approval · Notice of Compliance 18513 · 2016
MINT-LEVOCARB: Notice of Compliance 18513
Issued September 23, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18513
- Date
- September 23, 2016
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- SINEMET (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-LEVOCARB | 02457954 | Marketed |
| MINT-LEVOCARB | 02457962 | Marketed |
| MINT-LEVOCARB | 02457970 | Dormant |